Wenxia Luo

POSTDOCTORAL RESEARCHER

Dr. Wenxia Luo is a Postdoctoral Researcher at Thryv Therapeutics, where she focuses on drug metabolism and pharmacokinetics (DMPK) studies supporting the discovery and development of novel SGK1 inhibitors. She brings over 10 years of experience in analytical and bioanalytical research, with expertise in LC-MS/MS method development and validation, quantitative bioanalysis, pharmacokinetics, and in vitro ADME studies.

Dr. Luo holds a PhD in Pharmaceutical Sciences from the University of Manitoba. Before joining Thryv, she gained research experience in academic and industry settings, including the National University of Singapore and an analytical contract research organization in China.